Immunohistochemical Evaluation of FGD3 Expression: A New Strong Prognostic Factor in Invasive Breast Cancer.

Susini, Tommaso; Saccardin, Giulia; Renda, Irene; Giani, Milo; Tartarotti, Enrico; Nori, Jacopo; Vanzi, Ermanno; Pasqualini, Elisa; Bianchi, Simonetta

Susini, Tommaso; Saccardin, Giulia; Renda, Irene; Giani, Milo; Tartarotti, Enrico; Nori, Jacopo; Vanzi, Ermanno; Pasqualini, Elisa; Bianchi, Simonetta.

Affiliation

Susini T; Breast Unit, Gynecology Section, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Saccardin G; Breast Unit, Gynecology Section, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Renda I; Breast Unit, Gynecology Section, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Giani M; Breast Unit, Gynecology Section, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Tartarotti E; Breast Unit, Gynecology Section, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Nori J; Diagnostic Senology Unit, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.
Vanzi E; Diagnostic Senology Unit, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.
Pasqualini E; Pathology Unit, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Bianchi S; Pathology Unit, Department of Health Sciences, University of Florence, 50134 Florence, Italy.

Cancers (Basel) ; 13(15)2021 Jul 29.

Article in En | MEDLINE | ID: mdl-34359725

Key words

FGD3 gene; breast cancer; precision medicine; prognostic factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google